180 Degree Capital (180 Degree Capital) Valuation Rank

View and export this data going back to 1992. Start your Free Trial

What is 180 Degree Capital Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

180 Degree Capital Valuation Rank Related Terms

Thank you for viewing the detailed overview of 180 Degree Capital's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

180 Degree Capital (180 Degree Capital) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » 180 Degree Capital Corp (NAS:TURN) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 N. Willow Street, Suite 4B, Montclair, NJ, USA, 07042

Website

http://www.180degreecapital.com

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

Executives

Kevin Rendino	director	800 SCUDDERS MILL RD, PLAINSBORO NJ 08536
Daniel B Wolfe	officer: Vice President	HARRIS & HARRIS GROUP, 111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Bigelow Robert E Iii	officer: VP, Head of Fund Development	7 NORTH WILLOW STREET SUITE 4B, MONTCLAIR NJ 07042
Alicia M Gift	officer: Treasurer, Secretary	1450 BROADWAY, 24TH FLOOR, NEW YORK NY 10018
Richard P Shanley	director	111 WEST 57TH STREET, NEW YORK NY 10019
Tonia L Pankopf	director	8 SOUND SHORE DR STE 215, GREENWICH CT 06830
Parker Anders Weil	director	262 MCKINLEY PLACE, RIDGEWOOD NJ 07450
Stacy Brandom	director	1450 BROADWAY, NEW YORK NY 10018
Robert Stephen Burns	officer: Senior Vice President	1450 BROADWAY, NEW YORK NY 10018
Bruce W Shewmaker	director	12 BRIAR WOOD DRIVE, SHORT HILLS NJ 07078
Lucio Lanza	director	141 CASPIAN COURT, SUNNYVALE CA 94089
Misti Ushio	officer: Vice President	111 WEST 57TH STREET, NEW YORK NY 10019
Charles E Ramsey	director	111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Ayres W Dillaway Jr	director	111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Michael A Janse	officer: Executive Vice President	111 WEST 57TH STREET SUITE 1100, NEW YORK NY 10019